Tornado-damaged Pfizer plant in North Carolina restarts production
- Pfizer has resumed production at its pharmaceutical plant in North Carolina that was severely damaged by a tornado, with the priority given to 13 medicines based on patient need and inventory levels.
- The damaged plant is responsible for supplying nearly 8% of all sterile injectable medicines used in U.S. Hospitals, making the restarting of production a significant achievement for Pfizer.
- While most production lines have been restarted, some medicines may still face shortages until at least mid-2024. Pfizer continues to monitor emergency requests for certain medicines from the Rocky Mount plant.
25 Articles
25 Articles
Tornado-damaged Pfizer plant in North Carolina restarts production
ROCKY MOUNT, N.C. (AP) — A major Pfizer pharmaceutical plant in North Carolina that makes critical supplies for U.S. hospitals has restarted production about 10 weeks after it was heavily damaged by a tornado, the company announced Monday.
Tornado-damaged Pfizer plant in North Carolina restarts production
ROCKY MOUNT, N.C. (AP) — A major Pfizer pharmaceutical plant in North Carolina that makes critical supplies for U.S. hospitals has restarted production about 10 weeks after it was heavily damaged by a tornado, the company announced Monday. Getting a majority of manufacturing lines at the Rocky Mount facility back up and running is a “proud achievement,” Pfizer said in a statement. Full production across the facility’s three manufacturing sites i…
Coverage Details
Bias Distribution
- 55% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage